ArticleClinical and translational radiation oncology2026
Wide dural radiation therapy for NF2-SWN associated meningiomatosis.
Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Neurofibromatosis type 2-related schwannomatosis ( Materials and Methods: Ten Results: Median age was 41 years (range 25-53) with a median follow-up of 45.8 months. All patients initiated WDRT for growing lesions or worsening symptoms. Median doses were 54 Gy to gross lesions and tumor bed and 48 Gy to the wide dural field (30 fractions). Ninety-one meningiomas with sizes greater than 5 mm received doses 48 Gy or higher with no infield progression. The 2-year LC rate was 100%, though follow-up remains limited for definitive long-term assessment. Three patients (30%) experienced outfield progression (median 31.3 months): two in intentionally untreated lesions (to be later treated with either surgery or radiosurgery) and one marginal recurrence at the edge of the supratentorial field. Two patients experienced acute grade 2 toxicity including nausea and headache. Conclusion: WDRT provides excellent local control and adequate safety profiles in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.